PDB68 - COST-EFFECTIVENESS ANALYSIS OF EXENATIDE VERSUS GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.773
https://www.valueinhealthjournal.com/article/S1098-3015(18)34073-7/fulltext
Title :
PDB68 - COST-EFFECTIVENESS ANALYSIS OF EXENATIDE VERSUS GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34073-7&doi=10.1016/j.jval.2018.09.773
First page :
Section Title :
Open access? :
No
Section Order :
170